Medicenna Therapeutics (MDNA)

MDNA IL-4/IL-13 Oncology

BiotechSign Signal Grade

F
Signal Grade
10.4/100 composite signal score

Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.

Insider Buying
0
Clinical Activity
17

Pipeline Overview

Therapeutic Focus
IL-4/IL-13 Oncologysrc

Clinical Trial Activity

1
Clinical Trial
(ClinicalTrials.gov aggregate)
1 Phase 1, 1 Phase 2
Trial Phase Breakdown
0
PubMed Publications
0
Catalyst Records

ClinicalTrials.gov aggregate as of 2026-10-06. ClinicalTrials.gov

Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Medicenna Therapeutics.

Full MDNA Dashboard Sign Up Free

Primary Sources

This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.